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Abstract
Background
The association between Cryptosporidium and human colon cancer has been reported in
different populations. However, this association has not been well studied. In order to add
new strong arguments for a probable link between cryptosporidiosis and colon human can-
cer, the aim of this study was to determine prevalence and to identify species of Cryptospo-
ridium among Lebanese patients.
Methodology and principal findings
Overall, 218 digestive biopsies were collected in Tripoli, Lebanon, from three groups of
patients: (i) patients with recently diagnosed colon intraepithelial neoplasia/adenocarcinoma
before any treatment (n = 72); (ii) patients with recently diagnosed stomach intraepithelial
neoplasia/adenocarcinoma before any treatment (n = 21); and (iii) patients without digestive
intraepithelial neoplasia/adenocarcinoma but with persistent digestive symptoms (n = 125).
DNA extraction was performed from paraffin-embedded tissue. The presence of the para-
site in tissues was confirmed by PCR, microscopic observation and immunofluorescence
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analysis. We identified a high rate (21%) of Cryptosporidium presence in biopsies from
Lebanese patients with recently diagnosed colonic neoplasia/adenocarcinoma before any
treatment. This prevalence was significantly higher compared to 7% of Cryptosporidium
prevalence among patients without colon neoplasia but with persistent gastrointestinal
symptoms (OR: 4, CI: 1.65–9.6, P = 0.001). When the comparison was done against normal
biopsies, the risk of infection increased 11-fold in the group of patients with colon adenocar-
cinoma (OR: 11.315, CI: 1.44–89.02, P = 0.003).
Conclusions
This is the first study performed in Lebanon reporting the prevalence of Cryptosporidium
among patients with digestive cancer. These results show that Cryptosporidium is strongly
associated with human colon cancer being maybe a potential etiological agent of this
disease.
Introduction
The protozoan Cryptosporidium constitutes a significant risk to humans and animals causing
self-limiting diarrhea in immunocompetent hosts and life-threatening disease in immuno-
compromised hosts. Recently, a cohort study involving 22,500 children living in Africa and
Asia revealed that Cryptosporidium represents one of the four pathogens responsible for severe
diarrhea and mortality in infants and toddlers [1,2]. Additionally, our team has discovered
that Cryptosporidium parvum, a species frequently isolated from humans and animals, is able
to induce digestive adenocarcinoma in a rodent model, being the first time that an eukaryotic
microorganism has been associated with neoplastic changes in the digestive epithelium of a
mammalian host [3–6]. Consistently, some epidemiological studies have reported an associa-
tion with cryptosporidiosis in patients with colorectal adenocarcinoma [7–9]. However, the
correlation between cryptosporidiosis and human digestive cancer remains unclear at this
time, and it is not known whether this intracellular parasite, considered an opportunistic
agent, is able to induce gastrointestinal malignancies in humans. Therefore, these experimental
and clinical observations represent a strong recommendation for further clinical research into
the causal involvement of Cryptosporidium spp. in human digestive cancer. In order to add
new arguments for a probable association between cryptosporidiosis and digestive human can-
cer, the main aim of this study was to determine prevalence and to identify species of Crypto-
sporidium among a Lebanese digestive cancer population. Interestingly, a high rate (21%) of
Cryptosporidium presence was found in biopsies from Lebanese patients with recently diag-
nosed colonic neoplasia/adenocarcinoma before any treatment. These results provide new
data about a potential role of this parasite in the development of colon adenocarcinoma. How-
ever, further studies are needed to reach definitive conclusions about this association.
Materials and methods
Ethics statement
This study was approved from the Lebanese Minister of Public Health (reference number:
4–39716). In accordance with the ethical standards of the Lebanese legislation physicians
within the common clinical practice orally informed all adult patients about potential utili-
zation of biopsies for research or secondary purpose, and participants manifested verbally
Cryptosporidium infection and colon cancer
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their non-opposition. To obtain written consent was not possible due to the fact that this
study was retrospective. However, attestation statements signed by the physicians recording
the verbal non-opposition manifested by participants were obtained. Data were analysed
anonymously.
Study population and sample collection
Digestive biopsies fixed in formalin and embedded in paraffin were collected in Tripoli, Leba-
non, between 2012 and 2013 from three groups of patients: (i) patients with recently diagnosed
colon intraepithelial neoplasia/adenocarcinoma before any treatment (n = 72); (ii) patients
with recently diagnosed stomach intraepithelial neoplasia/adenocarcinoma before any treat-
ment (n = 21); and (iii) patients without colon or stomach intraepithelial neoplasia/adenocar-
cinoma but with persistent digestive symptoms that justified biopsy sampling (n = 125). For
the purpose of statistical analysis the experimental group (i) was compared to different sub-
groups: a) all patients of groups (ii) and (iii) (n = 146). b) patients of group (iii) without colonic
neoplasia but with other colonic pathology such as diverticulitis, colitis, polyps, inflammatory
disease, etc. (n = 72); c) patients of group (iii) with a normal digestive biopsy (n = 44). In this
group only patients without evidence of histological alterations were included. Finally group
(i) was also compared to group (ii). The sample size corresponds to the number of samples
that we could collect during a specific period due to logistic reasons. All patients were negative
for human immunodeficiency virus.
DNA extraction
Paraffined sections were treated with xylene and ethanol and then rehydrated. To disrupt the
wall of potential oocysts, the samples were lysed using glass beads (Sigma Aldrich, Germany).
DNA was extracted from 2 sections of 30 μm from each block using the QIAamp DNA Mini
Kit (Qiagen GmbH, Hilden, Germany). The extracted DNA was quantified by a spectropho-
tometer by Nanodrop. In order to test fragmentation, 10 μl of DNA samples randomly selected
were electrophoresed on a 1% agarose gel containing 0.5 μg/ml ethidium bromide. The gel was
run at a low voltage and DNA ladders were finally visualized by a UV light. To avoid the risk
of cross-contaminations between two consecutive paraffin blocks histological standard proce-
dures for cleaning workspace and instruments were applied.
Real-time PCR for Cryptosporidium spp. detection
The 18S rRNA real-time PCR was performed as previously described [10]. Positive PCR prod-
ucts were purified and sequenced by Genoscreen (Pasteur Institute, Lille, France). The
sequences obtained were aligned using the BioEdit v7.0.1 package, and then compared with
sequences of Cryptosporidium published in the NCBI. To avoid contamination of the histologi-
cal samples standard procedures for cleaning workspace and instruments were applied includ-
ing extensive microtome washing with DNA decontamination solution with each new sample
section.
Histological examination
Cryptosporidium was detected in histological sections after hematoxylin-eosin staining and
immunofluorescence using a fluorescein isothiocyanate (FITC)-conjugated anti-Cryptosporid-
ium spp. monoclonal antibody (Cellabs, Brookvale, New South Wales, Australia).
Cryptosporidium infection and colon cancer
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Epstein-Barr virus detection
Genomic detection and quantification of Epstein-Barr virus (EBV) was performed from 10 μl
of DNA using the quantitative EBV R-gene test system (Argene, BioMe´rieux Marcy l’Etoile,
France).
Statistical analysis
For the statistical analysis, Fisher’s exact test was used to test the relationship between different
categorical variables. Odds ratios were calculated with Cryptosporidium infection as the main
outcome using a logistic regression model.
A multivariate binary logistic regression analysis was used to test statistical relationship
between Cryptosporidium infection and colon intraepithelial neoplasia/adenocarcinoma status
taking in account confounding effect such as patient age, sex and affected organs. The general
significance level was set at a P-value below 0.05. All analyses were performed using Vassarstats
software and packages stats from the R statistical computing program [11].
Results
A total of 218 biopsies were collected in this study. The age of the patients was between 18 and
92 years (mean age: 50 ± 19). No significant differences related to age or sex were observed
between groups. However, in patients with Cryptosporidium infection and colon neoplasia, the
median age at time of diagnosis was lower compared to those patients with colon neoplasia
without infection (X = 57,7 vs. X = 60.19). Additionally, the age distribution in these two
groups differed considerably (Fig 1): for the second group, the age range was wider when com-
pared to the first one, even if this difference was not significant. A possible explanation would
be that the group control may include those persons with hereditary factors that predispose to
get colon cancer before 30s but unfortunately, this kind of information was not available.
After DNA quantitation and quality assessment, using qPCR, Cryptosporidium infection
was detected in 21% (15/72) of patients with recently diagnosed colon intraepithelial neopla-
sia/adenocarcinoma compared to 7% (9/146) of patients without digestive neoplasia but with
persistent gastrointestinal symptoms, where the risk of Cryptosporidium infection was thus 4
times higher in the first group (OR: 4, CI: 1.65–9.6, P = 0.001). Similarly, when considering
Fig 1. Age distribution among groups of patients with colonic neoplasia, infected or not by
Cryptosporidium. Each box represents half of the data between upper and lower quartile, the black line
being the median.
https://doi.org/10.1371/journal.pone.0189422.g001
Cryptosporidium infection and colon cancer
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only colon disease, patients with colon intraepithelial neoplasia/adenocarcinoma also had a 4
times higher risk of Cryptosporidium infection than patients without neoplasia but with other
colon pathologies (OR: 4.05, CI: 1.39–11.79, P = 0.006). When the comparison was done using
normal biopsies, the risk of infection increased 11-fold in the group of patients with colon ade-
nocarcinoma (OR: 11.315, CI: 1.44–89.02, P = 0.003). Cryptosporidium infection was found
only in colonic but not in gastric neoplasia samples, and this difference was significant
(P = 0.014) (Table 1).
Additionally, we checked that positive cases did not involve consecutive samples and the
presence of the parasite in tissues was verified by microscopic observation.
The multivariate binary logistic regression analysis showed that the variable colonic neopla-
sia/cancer continued to be significantly associated to Cryptosporidium infection after adjusting
by age, sex or affected organ (Table 2). Inflammation was not significantly associated with
the presence of the parasite (P = 0.3). After genotyping Cryptosporidium positive cases, two
Cryptosporidium species were found: 19 (79.2%) samples were identified as C. hominis, while 5
(20.8%) were identified as C. parvum. When only colon intraepithelial neoplasia/adenocarci-
noma was considered, this proportion was maintained: the presence of 7 (78%) C. hominis and
Table 1. Frequency of Cryptosporidium infection in biopsies from patients with colonic intraepithelial neoplasia/adenocarcinoma compared to
control groups.
Groups () and Subgroups [] Presence of
Cryptosporidium N (%)
Absence of
Cryptosporidium N (%)
OR 95% CI P-value
Colonic intraepithelial neoplasia/adenocarcinoma (i) 15/72 (20.83) 57/72 (79.16) 4.006 (1.65–9.679) 0.0016*
Other digestive pathologies [a] 9/146 (6.16) 137/146 (93.83)
Colonic intraepithelial neoplasia/adenocarcinoma (i) 15/72 (20.83) 57/72 (79.16) 4.05 (1.39–11.79) 0.0062*
Other colonic pathologies (without intraepithelial
neoplasia/adenocarcinoma) [b]
5/82 (6.09) 77/82 (93.90)
Colonic intraepithelial neoplasia/adenocarcinoma (i) 15/72 (20.83) 57/72 (79.16) 11.315 (1.44–89.02) 0.0031*
Normal digestive biopsies [c] 1/44 (2.27) 43/44 (97.72)
Colonic intraepithelial neoplasia/adenocarcinoma (i) 15/72 (20.83) 57/72 (79.16) NA NA 0.01*
Gastric intraepithelial neoplasia/adenocarcinoma (ii) 0/21 (0) 21/21(100)
NA/Not applicable.
(i) patients with recently diagnosed colon intraepithelial neoplasia/adenocarcinoma before any treatment (n = 72); (ii) patients with recently diagnosed
stomach intraepithelial neoplasia/adenocarcinoma before any treatment (n = 21); and (iii) patients without colon or stomach intraepithelial neoplasia/
adenocarcinoma but with persistent digestive symptoms that justified biopsy sampling (n = 125). For the purpose of statistical analysis the experimental
group (i) was compared to different subgroups: a) all patients of groups (ii) and (iii) (n = 146). b) patients of group (iii) without colonic neoplasia but with other
colonic pathology such as diverticulitis, colitis, polyps, inflammatory disease, etc. (n = 72); c) patients of group (iii) with a normal digestive biopsy (n = 44). In
this group only patients without evidence of histological alterations were included. Finally group (i) was also compared to group (ii).
* Significant P-value.
https://doi.org/10.1371/journal.pone.0189422.t001
Table 2. Multivariate binary logistic regression analysis of the association between Cryptosporidium infection and colonic neoplasia/cancer
development, age, sex or affected organ.
Variables Estimate Std. Error Z value P-value
Colonic neoplasia/ cancer 1.06350 0.50478 2.107 0.0351*
Age -0.01439 0.01307 -1.101 0.2709
Sex -0.00817 0.45139 -0.018 0.9856
Affected organ -0.67756 0.58021 -1.168 0.2429
* Significant P-value.
https://doi.org/10.1371/journal.pone.0189422.t002
Cryptosporidium infection and colon cancer
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2 (22%) C. parvum isolates was confirmed. The sequences obtained showed 100% identity with
GenBank reference sequences. There were not differences in the risk for colon cancer when
these species were considered independently. The presence of the parasites in tissues was con-
firmed by microscopic observation in 11 colonic neoplastic sections out of 15 (Fig 2).
In order to exclude EBV, an oncogenic pathogen potentially responsible for colon cancer,
biopsies from cancerous and control subjects were analyzed. Results showed a homogeneous
distribution of the virus among groups of Cryptosporidium-infected and non-infected patients,
as well as among subjects with and without colon cancer.
Discussion
The data herein indicates that Cryptosporidium was highly prevalent among Lebanese patients
with colon intraepithelial neoplasia/adenocarcinoma, and this prevalence was significantly
higher compared with the burden of cryptosporidiosis in control groups.
This prevalence of Cryptosporidium detected in these patients is also higher compared with
prevalence reported in previous Lebanese epidemiological studies: 10% in Cryptosporidium-
symptomatic patients and schoolchildren, and 5% detected in the general population [12,13],
while the prevalence in the control group was in the range previously reported in the general
Lebanese population [12].
Our results also showed a homogeneous distribution of other potential oncogenic patho-
gen, such as EBV [14] among groups, consistent with the fact that this virus infects almost
everyone in early life and persists throughout life.
On the other hand, the molecular characterization of Cryptosporidium isolates allowed the
identification of either C. hominis or C. parvum, with the former being predominant (79%).
These results confirm recent reports in Lebanon showing the presence of these two species
with the predominance of C. hominis [12]. Furthermore, for the first time, C. hominis has been
associated with colon adenocarcinoma.
Because Cryptosporidium is an opportunistic agent that causes significant morbidity and
mortality in immunocompromised patients, it is possible that individuals with malignancies,
have a higher risk of developing infection with this parasite, especially when their immunosup-
pression is more severe. In this study, samples originated from recently diagnosed HIV nega-
tive patients, and before any treatment to avoid the decline in CD4+ and CD8+ T-cell counts.
Then, the risk of an opportunistic infection due to the presence of cancer as immunodebilitat-
ing condition seemed to be low. However, one of the limitations of this study was the lack of
Fig 2. Histological sections from a colon adenocarcinoma associated to Cryptosporidium infection.
(A) Cryptosporidium developmental stages were observed in the apical position (arrows) within the epithelial
cells of the intestinal glands (hematoxylin and eosin). (B) A Cryptosporidium oocyst is shown (arrow) in the
lumen of an intestinal gland after immunofluorescence (fluorescein isothiocyanate (FITC)-conjugated anti-
Cryptosporidium spp. MAbs.) (C) Four sporozoites in the oocyst were observed (arrow) (staining with
4,6-diamidino 2-phenylindole dihydrochloride (DAPI)).
https://doi.org/10.1371/journal.pone.0189422.g002
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information concerning the CD4+ and CD8+ counts of these patients. Further studies should
be done taking into account this variable.
Associations between Cryptosporidium infection and digestive neoplasia in different popu-
lations have been described. A recent study conveyed that the risk of developing a colon
carcinoma is significantly elevated among AIDS patients presenting cryptosporidiosis [9]. A
possible association between human cryptosporidiosis and bile-duct carcinoma was suggested
in children with X-linked hyper-IgM syndrome [15].
Furthermore, epidemiological studies in Poland reported a frequency of 18% and 12.6% of
cryptosporidiosis in patients with recently diagnosed colorectal cancer before any immuno-
suppressive treatment, but in these studies the species responsible for infection were not deter-
mined [7, 8].
In fact, the potential role of Cryptosporidium in the development of neoplasia would not be
surprising, considering that epidemiological and clinical reports indicate that eukaryotic pro-
tozoan, such as intracellular apicomplexan that cause diseases of medical or economic impor-
tance, can be linked to various cancers, for instance: Theileria induce host cell transformation
while Plasmodium was linked epidemiologically to the "African lymphoma belt" over fifty
years ago [16]. These intracellular eukaryotic parasites hijack cellular pathways to manipulate
the host cell epigenome, cellular machinery, signaling pathways and epigenetic programs and
marks, such as methylation and acetylation, for their own benefit [16].
Particularly, it has been reported that C. parvum for its survival and transmission interferes
with host signaling pathways [17, 18]. For instance, in an in vitro model of biliary cryptospo-
ridiosis C. parvum was shown to activate the NF-κB pathway in infected cells, preventing the
induction of apoptosis after infection [19]. Interestingly, NF-κB family of transcription factors
regulates the activation of several intracellular survival signals including the c-Myc protoonco-
gene. Indeed, activation of NF-κB has been observed in many cancers, including colon cancer
[20]. However, it has been found in in vitro studies that C. parvum, can modulate host-cell
apoptosis, inhibiting apoptosis at the trophozoite stage and promoting this process at the spo-
rozoite and merozoite stages [21]. Modulation of apoptotic pathways was also investigated by
microarray analysis in an in vitro model using human ileocaecal HCT8 cells. Genome wide
expression profiling revealed high proportion of apoptosis genes regulated during C. parvum
infection [22]. In fact, resistance to apoptosis could be a crucial step in the progression to
malignancy [17].
Moreover, it is well known that the parasite induces modifications of the host actin cyto-
skeleton of intestinal epithelial cells although little information is available about the signifi-
cance of the host actin remodelling process. Several studies reported that infection of intestinal
and biliary epithelial cells requires host cell actin polymerization and cytoskeleton remodelling
[18]. This polymerization uses the actin branching and nucleation machinery of the Arp2/
3complex of proteins. Several signaling axes such as those of PI3-kinase, guanine exchange fac-
tor, Frabin-dependent activation of the small GTPase, and CDC42- and c-Src-dependent acti-
vation of cortactin have been identified to modulate actin reorganization and Cryptosporidium
internalization [18]. In consistence, recently it was found hat C. parvum, independently of the
strain, is able to modulate host cytoskeleton activities and several host-cell biological processes
via the Wnt signaling pathway in SCID mice [23].
Conclusions
This is the first study performed in Lebanon reporting the prevalence of Cryptosporidium
among patients with digestive cancer. These results show that Cryptosporidium is strongly
associated with human colon cancer providing new data about a potential role of this parasite
Cryptosporidium infection and colon cancer
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in the development of colon adenocarcinoma. However, further studies are needed to reach
definitive conclusions about this association. The last but not least, changes in bowel habits,
including diarrhea, have been found as significant predictors of colorectal cancer. Maybe pres-
ence of Cryptosporidium infection could be one of the causes explaining these symptoms.
Research into this topic would be worthwhile, since the incidence of Cryptosporidium infec-
tion seems to be increasing worldwide [1,2,13,24]. In addition, the World Health Organization
acknowledges that nowadays 20% of cancers are due to infectious agents, and some authors
have hypothesized that within 2050 the great majority of cancers will be considered to have an
infectious origin [25].
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